SERIO, Bianca
 Distribuzione geografica
Continente #
AS - Asia 6.059
NA - Nord America 1.860
EU - Europa 1.173
SA - Sud America 331
AF - Africa 61
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.489
Nazione #
HK - Hong Kong 4.515
US - Stati Uniti d'America 1.794
SG - Singapore 788
CN - Cina 273
IT - Italia 253
DE - Germania 249
BR - Brasile 247
RU - Federazione Russa 221
VN - Vietnam 221
FI - Finlandia 91
IN - India 74
ES - Italia 72
FR - Francia 66
GB - Regno Unito 54
AR - Argentina 37
AT - Austria 32
CA - Canada 32
KR - Corea 30
IE - Irlanda 25
BD - Bangladesh 24
CZ - Repubblica Ceca 24
MX - Messico 24
NL - Olanda 24
ZA - Sudafrica 21
JP - Giappone 20
SE - Svezia 17
PL - Polonia 16
IQ - Iraq 15
TR - Turchia 15
EC - Ecuador 14
ID - Indonesia 11
MA - Marocco 10
CO - Colombia 9
EG - Egitto 9
MY - Malesia 9
PK - Pakistan 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 6
PY - Paraguay 6
VE - Venezuela 6
CL - Cile 5
MD - Moldavia 5
LB - Libano 4
PH - Filippine 4
TN - Tunisia 4
UA - Ucraina 4
BH - Bahrain 3
DZ - Algeria 3
HN - Honduras 3
IL - Israele 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
LT - Lituania 3
PE - Perù 3
SA - Arabia Saudita 3
AL - Albania 2
AO - Angola 2
AU - Australia 2
AZ - Azerbaigian 2
BE - Belgio 2
GR - Grecia 2
HR - Croazia 2
KG - Kirghizistan 2
NI - Nicaragua 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BJ - Benin 1
BO - Bolivia 1
BW - Botswana 1
BZ - Belize 1
CG - Congo 1
CH - Svizzera 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
GE - Georgia 1
IR - Iran 1
JM - Giamaica 1
KW - Kuwait 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MK - Macedonia 1
MM - Myanmar 1
MN - Mongolia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
Totale 9.484
Città #
Hong Kong 4.504
Singapore 384
San Jose 382
Dallas 322
Ashburn 215
Munich 182
Chandler 80
Ho Chi Minh City 71
Council Bluffs 69
Beijing 62
Lauterbourg 57
Valencia 52
Hanoi 51
Los Angeles 48
Helsinki 46
Moscow 40
Nuremberg 40
The Dalles 37
Naples 36
New York 35
Rome 34
Santa Clara 33
Turku 29
Orem 27
Princeton 27
São Paulo 27
Brno 22
Dublin 22
Amsterdam 19
Frankfurt am Main 19
Chennai 18
Montreal 17
Denver 16
Milan 16
Tokyo 16
Warsaw 16
Johannesburg 15
Stockholm 14
Rio de Janeiro 13
Salerno 13
Atlanta 12
Poplar 12
Vienna 12
Chicago 11
Haiphong 11
London 11
Seattle 11
Curitiba 10
Fisciano 10
Washington 10
Houston 9
Mumbai 9
Phoenix 9
West Jordan 9
Boardman 8
Boydton 8
Da Nang 8
Hải Dương 8
Lappeenranta 8
Pune 8
Biên Hòa 7
Brooklyn 7
City of London 7
Mexico City 7
Seoul 7
Tashkent 7
Baghdad 6
Belo Horizonte 6
Brasília 6
Milwaukee 6
Perugia 6
Yancheng 6
Ankara 5
Cairo 5
Cava De' Tirreni 5
Domicella 5
Genoa 5
Jyväskylä 5
Lahore 5
Manchester 5
San Francisco 5
Shanghai 5
Toronto 5
Turin 5
Albanella 4
Andover 4
Boston 4
Buffalo 4
Dhaka 4
Fort Worth 4
Jacksonville 4
Juiz de Fora 4
Kuala Lumpur 4
Medellín 4
Nanjing 4
New Delhi 4
Paris 4
Pisa 4
Quito 4
São Bernardo do Campo 4
Totale 7.522
Nome #
Low-Density Granulocytes Are Decreased in Acute Myeloid Leukemia and in Myelodysplastic Syndromes with Negative Prognostic Factors 653
Cytopathological differential diagnosis of malignant tumor cells in the cerebrospinal fluid: A retrospective analysis 607
Hemopoiesis and Immune Cell Perturbations during Venetoclax Plus Azacytidine Treatment in Acute Myeloid Leukemia 490
DECREASED LOW-DENSITY GRANULOCYTES AS POSSIBLE DIAGNOSTIC MARKERS OF MYELODYSPLASTIC SYNDROMES WITH EXCESS OF BLASTS 481
Artificial Intelligence in Hypertension Management: An Ace up Your Sleeve 461
Hodgkin Lymphoma and Hairy Cell Leukemia Arising from Chronic Lymphocytic Leukemia: Case Reports and Literature Review 416
Immature forms of low density granulocytes are increased in acute myeloid leukemia and myelodysplastic syndromes 340
WT1 Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes 328
A Rare Immune-Related Mesenteric and retroperitoneal serositis in a Multi-Refractory Hodgkin Lymphoma Patient Successfully Treated with Chylolymphostatic Surgery 323
All Roads Lead to Interferon-γ: From Known to Untraveled Pathways in Acquired Aplastic Anemia 283
The Current and Future Impact of Lymph Node Fine-Needle Aspiration Cytology on Patient Care 248
Clinical efficacy of azacytidine and venetoclax and prognostic impact of Tim-3 and galectin-9 in acute myeloid leukemia and high-risk myelodysplastic syndromes: A single-center real-life experience 246
Contribution of peripheral blood mononuclear cells isolated by advanced filtration system to myogenesis of human bone marrow mesenchymal stem cells co-cultured with myoblasts 222
Giant plasma cells with multiple immature nuclei in a young woman with newly diagnosed multiple myeloma 215
Cytomegalovirus reactivation is frequent in multiple myeloma patients treated with daratumumab-based regimens 193
Circulating T Regulatory Cells Are Persistently Reduced in Non-Severe Acquired Aplastic Anemia 162
Electrophysiological Studies in Combination With Interim-Positron Emission Tomography Scan for Prevention of Severe Brentuximab-Vedotin-Induced Neurotoxicity 135
Combined fine needle aspiration cytology and core needle biopsy in the same setting: A two-years' experience 134
SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency 122
BRAF V600E mutation associated with papillary high-grade serous ovarian cystadenocarcinoma in a 22q11.2DS patient 118
Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens 117
BONE MARROW MESENCHYMAL STEM CELLS AS FACILITATOR OF RUXOLITINIB-MEDIATED INHIBITION OF JAK2 MUTADED CELLS 114
An economic evaluation of fine-needle cytology as the primary diagnostic tool in the diagnosis of lymphadenopathy 109
Antimicrobial Susceptibility Profiles of Klebsiella pneumoniae Strains Collected from Clinical Samples in a Hospital in Southern Italy 108
Clinical Efficacy of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients 99
Actinomycosis mimicking malignancy: a report of three cases diagnosed with fine-needle aspiration cytology 98
Sex, Age, and Previous Herpes Zoster Infection Role on Adverse Events Following Immunization with Adjuvanted Recombinant Vaccine 93
c-Kit M541L variant is related to ineffective hemopoiesis predisposing to clonal evolution in 3D in vitro biomimetic co-culture model of bone marrow niche 92
Biomimetic proteolipid vesicles for reverting GPI deficiency in paroxysmal nocturnal hemoglobinuria 91
Clinical Utility of TRBC1 Addition in Multiparametric Flow Cytometry for T Cell Lymphoma Diagnosis 91
OPSI threat in hematological patients 91
Non-invasive prenatal test identifies circulating cell-free DNA chromosomal abnormalities derived from clonal hematopoiesis in aggressive hematological malignancies 85
A Frail Hairy Cell Leukemia Patient Successfully Treated with Pegylated Interferon-α-2A 83
Implementation of International Prognostic Index with flow cytometry immunophenotyping for better risk stratification of chronic lymphocytic leukemia 82
Reduced Proliferative Potential with Conserved Stem/Stromal Phenotype of Human Umbilical Cord Mesenchymal Stem Cells in Placental Syndromes: A Prospective Cohort Study 79
Lenalidomide-induced psoriasis in a refractory multiple myeloma patient successfully treated with narrowband ultraviolet B 77
SERUM FREE LIGHT CHAIN RATIO AS A BIOMARKER OF MULTIPLE MYELOMA PROGRESSION AND ASSOCIATED RENAL DISEASE 76
Safety of Subcutaneous Daratumumab in Anti-CD38 Monoclonal Antibody-Naïve Patients with Plasma Cell Disorders: A Multicenter Real-Life Experience 75
Persistent decreased bone marrow CD3+CD56+ T lymphocytes are inversely associated with mature granulocytes in myelodysplastic syndromes 74
Efficacy and safety of belantamab-mafodotin in triple-refractory multiple myeloma patients: A multicentric real-life experience 73
CD38 prognostic role in chronic lymphocytic leukemia patients treated with standard chemotherapy or targeted agents: a monocentric real-life experience 73
Transient Daratumumab-Induced Refractive Shift in Multidrug-Resistant Multiple Myeloma: Case Report and Literature Review 72
Subclones with variants of uncertain clinical significance might contribute to ineffective hemopoiesis and leukemia predisposition 71
Inter-intra instrument comparison and standardization of a 10-color immunophenotyping for B and T cell non-Hodgkin lymphoma diagnosis and monitoring 70
Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study 68
Post-Transplant Cyclophosphamide (PTCY) as GVHD Prophylaxis for Hematopoietic Stem Cell Transplantation From Matched-Related Sibling Donors 67
Multiple myeloma characteristics correlated to serum free light chain ratio at diagnosis and association with early renal damage 66
Limited efficacy of 3 + 7 plus gemtuzumab ozogamycin in newly diagnosed fit intermediate genetic risk acute myeloid leukemia patients 65
Post-Transplant Cyclophosphamide versus Anti-Thymocyte Globulin in Patients with Hematological Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Haploidentical and Matched Unrelated Donors: A Real-Life Experience 65
Biclonality in hairy cell leukemia: Co-occurrence of CD10+ and CD10− clones with different surface membrane immunoglobulin expression 65
INTENSIFICATION AND MAINTENANCE WITH RITUXIMAB IN PATIENTS WITH DLBCL IN UNCERTAIN CR OR PR (PET-ORIENTED) AFTER INDUCTION THERAPY WITH R-CHOP OR SIMILAR THERAPIES; OUR EXPERIENCE 64
Effective Neutralizing Antibody Response Against SARS-CoV-2 Virus and Its Omicron BA.1 Variant in Fully Vaccinated Hematological Patients 63
Efficacy of Daratumumab-Based Regimens for Extramedullary Pulmonary Plasmacytoma: A Case Report 63
Letermovir Prophylaxis For Cytomegalovirus Reactivation in Allogeneic Stem Cell Transplantation: A Multicenter Italian Real-world Experience 63
INCREASE OF BONE EVENTS (FRACTURES) IN PATIENTS WITH AGGRESSIVE NON-HODGKIN LYMPHOMA: NEGATIVE SYNERGISM BETWEEN STEROIDS AND LOW MOLECULAR WEIGHT HEPARIN (LMWH)? OUR EXPERIENCE 61
Immunological derangement in hypocellular myelodysplastic syndromes 57
Letermovir Prophylaxis for Cytomegalovirus Infection in Allogeneic Stem Cell Transplantation: A Real-World Experience 56
Innovative Anti-CD38 and Anti-BCMA Targeted Therapies in Multiple Myeloma: Mechanisms of Action and Resistance 53
Macrophages and Urokinase Plasminogen Activator Receptor System in Multiple Myeloma: Case Series and Literature Review 51
Efficacy of Decitabine and Venetoclax as Salvage and Bridge Therapy to Haploidentical Hematopoietic Stem Cell Transplantation in a Multiresistant Acute Myeloid Leukemia Patient 50
Kaposi's sarcoma associated with chronic myeloid leukemia and imatinib mesylate therapy 48
ELTROMBOPAG IS AN EFFECTIVE TREATMENT OF POOR GRAFT FUNCTION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A GITMO SURVEY 41
Distinct immunologic kinetics and cytomegalovirus reactivation incidence with rituximab- versus obinutuzumab–bendamustine in follicular lymphoma: a single-center case series study 38
Oxidative Stress in Atopic Dermatitis and Possible Biomarkers: Present and Future 37
Impact of minimal residual disease response and of status of disease on survival after blinatumomab in B-cell acute lymphoblastic leukemia: results from a real-life study 37
Prolonged Hematogone Expansion Is Associated with Better Outcomes in Allogeneic Hematopoietic Stem Cell Transplantation Recipients 33
Secretory and Membrane-Associated Biomarkers of Mast Cell Activation and Proliferation 31
3D In Vitro Models of the Bone Marrow Niche 25
null 19
Efficacy of Momelotinib in Myelofibrosis Patients: Results From a Multicenter Study 8
Plasma Elastase Screening in Hematological Disease Reveals Its Potential as a Diagnostic and Prognostic Biomarker in Hematological Malignancies 7
Rituximab maintenance in marginal zone lymphoma: Evidence from a real-world single center case series study 6
Next generation sequencing reveals spatio-temporal clonal heterogeneity in an aggressive relapsed/refractory multiple myeloma case 3
Totale 9.580
Categoria #
all - tutte 24.771
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.771


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202125 0 0 0 0 0 0 0 0 0 7 14 4
2021/202251 3 0 0 10 3 1 0 2 2 1 3 26
2022/2023205 10 23 14 20 11 34 14 22 33 0 16 8
2023/2024392 35 29 30 29 34 53 35 23 10 17 27 70
2024/20251.177 31 22 17 40 58 102 301 94 202 53 113 144
2025/20267.730 419 2.618 2.220 384 528 219 529 131 315 367 0 0
Totale 9.580